Dusa Pharmaceuticals Inc.

29 Dunham Rd, Billerica, Massachusetts, United States

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

72.7%

Phase 3

18.2%

Trial Status Distribution

Completed

81.8%

Terminated

9.1%

Withdrawn

9.1%

Clinical Trials

Trials sponsored by this organization (11)

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

Phase 2

Completed

interventional

Mar 2016137 participants

Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

Phase 2

Completed

interventional

Feb 201614 participants

Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

Phase 2

Completed

interventional

Dec 201429 participants

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

Phase 2

Completed

interventional

Sep 2014166 participants

Twelve Month Follow-Up of CP0108

Completed

observational

Aug 2014206 participants

Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities

Phase 3

Completed

interventional

May 2014269 participants

Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)

Phase 2

Completed

interventional

Dec 2011235 participants

Page 1 of 2

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations